Metraipolis › archive › dc_7c3e47218ea1

Immune checkpoint inhibitor-induced cardiotoxicity: from immune mechanisms to clinical surveillance and targeted therapies — Europe PMC PMID:42591858

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42591858
DOI
10.3389/fcvm.2026.1872588
License (as archived)
solo-consultazione
Archived
2026-10-17T10:20:22.675Z
SHA-256 of the archived text
16af89af8d89c8bdc51adebf41de32b1179d4f2feaf0cd7dfbdbf62f3d6ad431
Stable URL of this page
https://metraipolis.com/documento/dc_7c3e47218ea1

How to cite

Immune checkpoint inhibitor-induced cardiotoxicity: from immune mechanisms to clinical surveillance and targeted therapies — Europe PMC PMID:42591858 — Europe PMC (en), https://europepmc.org/article/MED/42591858 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7c3e47218ea1 (Metraipolis archive dc_7c3e47218ea1, sha256 16af89af8d89c8bdc51adebf41de32b1179d4f2feaf0cd7dfbdbf62f3d6ad431)
BibTeX
@misc{dc7c3e47218ea1,
  title = {Immune checkpoint inhibitor-induced cardiotoxicity: from immune mechanisms to clinical surveillance and targeted therapies — Europe PMC PMID:42591858},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42591858},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7c3e47218ea1; sha256 16af89af8d89c8bdc51adebf41de32b1179d4f2feaf0cd7dfbdbf62f3d6ad431},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42591858. Agents can read the archived copy with the MCP tool read_document.